Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke?

Background and purpose:  Platelet stromal‐cell‐derived factor‐1 (SDF‐1) plays a pivotal role in angiogenesis and the regeneration of ischaemic tissue through the regulation of haematopoietic progenitor cells and is upregulated at the sites of vascular injury and platelet activation. Thus, SDF‐1 has...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of neurology 2012-03, Vol.19 (3), p.395-401
Hauptverfasser: Wurster, T., Stellos, K., Geisler, T., Seizer, P., Andia, M. E., Schuster, A., May, A. E., Melms, A., Gawaz, M., Bigalke, B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 401
container_issue 3
container_start_page 395
container_title European journal of neurology
container_volume 19
creator Wurster, T.
Stellos, K.
Geisler, T.
Seizer, P.
Andia, M. E.
Schuster, A.
May, A. E.
Melms, A.
Gawaz, M.
Bigalke, B.
description Background and purpose:  Platelet stromal‐cell‐derived factor‐1 (SDF‐1) plays a pivotal role in angiogenesis and the regeneration of ischaemic tissue through the regulation of haematopoietic progenitor cells and is upregulated at the sites of vascular injury and platelet activation. Thus, SDF‐1 has recently been discussed as a predictor in ischaemic diseases such as acute myocardial infarction. However, no clinical data pertinent to the investigation of the platelet SDF‐1 expression in patients with stroke are available. Methods:  We consecutively evaluated 196 patients who were admitted to the stroke unit with symptoms suspected for stroke. Surface expression of the platelet activation markers (P‐selectin and GPIb) and the expression of platelet‐bound SDF‐1 were determined by two‐colour whole blood flow cytometry. Results:  Patients with transient ischaemic attack (TIA) as well as with ischaemic stroke showed similar levels of SDF‐1 expression on hospital admission compared with patients with non‐ischaemic (NI) events and with 30 healthy controls (TIA (mean fluorescence intensity ± SD): 31.5 ± 18.2 vs. NI: 26.4 ± 15.7; P = 0.361; stroke: 28.7 ± 19.8 vs. NI; P = 0.943; control: 26.1 ± 11.3; P > 0.05 compared with all). Platelet SDF‐1 expression showed a trend with the severity of stroke according to National Institute of Health Stroke Scale score (r = 0.125; P = 0.085), but significantly correlated with the peak levels of C‐reactive protein (r = 0.218; P = 0.002) and with the levels of platelet activation (P‐selectin: r = 0.389; P = 0.001). Multifactorial analysis of covariance revealed a significant influence on platelet SDF‐1 expression by smoking (P = 0.019). Conclusions:  Platelet SDF‐1 surface expression did not show any significant difference in patients with TIA and ischaemic stroke compared with patients with NI events. Thus, single biomarker evaluation of platelet SDF‐1 surface expression is not helpful to predict ischaemic stroke.
doi_str_mv 10.1111/j.1468-1331.2011.03527.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_926892579</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>926892579</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4667-2ba0950077195e299c601a49c9fcd7fc3e39c83f82332826123f5e9fb2a4107a3</originalsourceid><addsrcrecordid>eNqNkUtPGzEURq2qVXm0fwGNxKJl4amvPX4hoaqCJK0UUQlKu7Qcjy0mzGRSO4Hw7_EQmkVXeOMr-5zra30IFUBKyOvLvIRKKAyMQUkJQEkYp7LcvEH7u4u3uWYcMAcCe-ggpTkhhEpK3qM9CppDRat9dDPaLKNPqekXRR-KtIp9Z1vsfNvi2sfm3tdFsG7VRwzF5-uLMYaT08IWWaqb4XiwmuRure8a9-zf-a8f0Ltg2-Q_vuyH6GY8-nX-HU9_Tn6cf5tiVwkhMZ1ZojkhUuZ5PNXaCQK20k4HV8vgmGfaKRYUZYwqKoCywL0OM2orINKyQ_Rp23cZ-79rn1amy7Pk2e3C9-tkNBVKUy71K0jgAoCoTB7_R877dVzkbxiQQihQirNMqS3lYp9S9MEsY9PZ-GiAmCEjMzdDFGaIwgwZmeeMzCarRy8PrGedr3fiv1AycLYFHprWP766sRldjoYq-3jrN2nlNzvfxjsjJJPc_LmcGBhPf19fVRNzxZ4AzOCrIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1766818853</pqid></control><display><type>article</type><title>Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke?</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Wurster, T. ; Stellos, K. ; Geisler, T. ; Seizer, P. ; Andia, M. E. ; Schuster, A. ; May, A. E. ; Melms, A. ; Gawaz, M. ; Bigalke, B.</creator><creatorcontrib>Wurster, T. ; Stellos, K. ; Geisler, T. ; Seizer, P. ; Andia, M. E. ; Schuster, A. ; May, A. E. ; Melms, A. ; Gawaz, M. ; Bigalke, B.</creatorcontrib><description>Background and purpose:  Platelet stromal‐cell‐derived factor‐1 (SDF‐1) plays a pivotal role in angiogenesis and the regeneration of ischaemic tissue through the regulation of haematopoietic progenitor cells and is upregulated at the sites of vascular injury and platelet activation. Thus, SDF‐1 has recently been discussed as a predictor in ischaemic diseases such as acute myocardial infarction. However, no clinical data pertinent to the investigation of the platelet SDF‐1 expression in patients with stroke are available. Methods:  We consecutively evaluated 196 patients who were admitted to the stroke unit with symptoms suspected for stroke. Surface expression of the platelet activation markers (P‐selectin and GPIb) and the expression of platelet‐bound SDF‐1 were determined by two‐colour whole blood flow cytometry. Results:  Patients with transient ischaemic attack (TIA) as well as with ischaemic stroke showed similar levels of SDF‐1 expression on hospital admission compared with patients with non‐ischaemic (NI) events and with 30 healthy controls (TIA (mean fluorescence intensity ± SD): 31.5 ± 18.2 vs. NI: 26.4 ± 15.7; P = 0.361; stroke: 28.7 ± 19.8 vs. NI; P = 0.943; control: 26.1 ± 11.3; P &gt; 0.05 compared with all). Platelet SDF‐1 expression showed a trend with the severity of stroke according to National Institute of Health Stroke Scale score (r = 0.125; P = 0.085), but significantly correlated with the peak levels of C‐reactive protein (r = 0.218; P = 0.002) and with the levels of platelet activation (P‐selectin: r = 0.389; P = 0.001). Multifactorial analysis of covariance revealed a significant influence on platelet SDF‐1 expression by smoking (P = 0.019). Conclusions:  Platelet SDF‐1 surface expression did not show any significant difference in patients with TIA and ischaemic stroke compared with patients with NI events. Thus, single biomarker evaluation of platelet SDF‐1 surface expression is not helpful to predict ischaemic stroke.</description><identifier>ISSN: 1351-5101</identifier><identifier>EISSN: 1468-1331</identifier><identifier>DOI: 10.1111/j.1468-1331.2011.03527.x</identifier><identifier>PMID: 21951424</identifier><identifier>CODEN: EJNEFL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Aged ; Aged, 80 and over ; Angiogenesis ; biomarkers ; Biomarkers - blood ; Blood Platelets - metabolism ; C-reactive protein ; Chemokine CXCL12 - analysis ; Chemokine CXCL12 - blood ; Data processing ; Female ; Flow Cytometry ; Fluorescence ; Hospitals ; Humans ; Injuries ; Ischemic Attack, Transient - blood ; Ischemic Attack, Transient - diagnosis ; Male ; Myocardial infarction ; P-selectin ; Platelets ; Regeneration ; SDF-1 ; SDF-1 protein ; Smoking ; Stem cells ; Stroke ; Stroke - blood ; Stroke - diagnosis ; TIA ; Transient ischemic attack</subject><ispartof>European journal of neurology, 2012-03, Vol.19 (3), p.395-401</ispartof><rights>2011 The Author(s). European Journal of Neurology © 2011 EFNS</rights><rights>2011 The Author(s). European Journal of Neurology © 2011 EFNS.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4667-2ba0950077195e299c601a49c9fcd7fc3e39c83f82332826123f5e9fb2a4107a3</citedby><cites>FETCH-LOGICAL-c4667-2ba0950077195e299c601a49c9fcd7fc3e39c83f82332826123f5e9fb2a4107a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1468-1331.2011.03527.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1468-1331.2011.03527.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21951424$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wurster, T.</creatorcontrib><creatorcontrib>Stellos, K.</creatorcontrib><creatorcontrib>Geisler, T.</creatorcontrib><creatorcontrib>Seizer, P.</creatorcontrib><creatorcontrib>Andia, M. E.</creatorcontrib><creatorcontrib>Schuster, A.</creatorcontrib><creatorcontrib>May, A. E.</creatorcontrib><creatorcontrib>Melms, A.</creatorcontrib><creatorcontrib>Gawaz, M.</creatorcontrib><creatorcontrib>Bigalke, B.</creatorcontrib><title>Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke?</title><title>European journal of neurology</title><addtitle>Eur J Neurol</addtitle><description>Background and purpose:  Platelet stromal‐cell‐derived factor‐1 (SDF‐1) plays a pivotal role in angiogenesis and the regeneration of ischaemic tissue through the regulation of haematopoietic progenitor cells and is upregulated at the sites of vascular injury and platelet activation. Thus, SDF‐1 has recently been discussed as a predictor in ischaemic diseases such as acute myocardial infarction. However, no clinical data pertinent to the investigation of the platelet SDF‐1 expression in patients with stroke are available. Methods:  We consecutively evaluated 196 patients who were admitted to the stroke unit with symptoms suspected for stroke. Surface expression of the platelet activation markers (P‐selectin and GPIb) and the expression of platelet‐bound SDF‐1 were determined by two‐colour whole blood flow cytometry. Results:  Patients with transient ischaemic attack (TIA) as well as with ischaemic stroke showed similar levels of SDF‐1 expression on hospital admission compared with patients with non‐ischaemic (NI) events and with 30 healthy controls (TIA (mean fluorescence intensity ± SD): 31.5 ± 18.2 vs. NI: 26.4 ± 15.7; P = 0.361; stroke: 28.7 ± 19.8 vs. NI; P = 0.943; control: 26.1 ± 11.3; P &gt; 0.05 compared with all). Platelet SDF‐1 expression showed a trend with the severity of stroke according to National Institute of Health Stroke Scale score (r = 0.125; P = 0.085), but significantly correlated with the peak levels of C‐reactive protein (r = 0.218; P = 0.002) and with the levels of platelet activation (P‐selectin: r = 0.389; P = 0.001). Multifactorial analysis of covariance revealed a significant influence on platelet SDF‐1 expression by smoking (P = 0.019). Conclusions:  Platelet SDF‐1 surface expression did not show any significant difference in patients with TIA and ischaemic stroke compared with patients with NI events. Thus, single biomarker evaluation of platelet SDF‐1 surface expression is not helpful to predict ischaemic stroke.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angiogenesis</subject><subject>biomarkers</subject><subject>Biomarkers - blood</subject><subject>Blood Platelets - metabolism</subject><subject>C-reactive protein</subject><subject>Chemokine CXCL12 - analysis</subject><subject>Chemokine CXCL12 - blood</subject><subject>Data processing</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>Fluorescence</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Injuries</subject><subject>Ischemic Attack, Transient - blood</subject><subject>Ischemic Attack, Transient - diagnosis</subject><subject>Male</subject><subject>Myocardial infarction</subject><subject>P-selectin</subject><subject>Platelets</subject><subject>Regeneration</subject><subject>SDF-1</subject><subject>SDF-1 protein</subject><subject>Smoking</subject><subject>Stem cells</subject><subject>Stroke</subject><subject>Stroke - blood</subject><subject>Stroke - diagnosis</subject><subject>TIA</subject><subject>Transient ischemic attack</subject><issn>1351-5101</issn><issn>1468-1331</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtPGzEURq2qVXm0fwGNxKJl4amvPX4hoaqCJK0UUQlKu7Qcjy0mzGRSO4Hw7_EQmkVXeOMr-5zra30IFUBKyOvLvIRKKAyMQUkJQEkYp7LcvEH7u4u3uWYcMAcCe-ggpTkhhEpK3qM9CppDRat9dDPaLKNPqekXRR-KtIp9Z1vsfNvi2sfm3tdFsG7VRwzF5-uLMYaT08IWWaqb4XiwmuRure8a9-zf-a8f0Ltg2-Q_vuyH6GY8-nX-HU9_Tn6cf5tiVwkhMZ1ZojkhUuZ5PNXaCQK20k4HV8vgmGfaKRYUZYwqKoCywL0OM2orINKyQ_Rp23cZ-79rn1amy7Pk2e3C9-tkNBVKUy71K0jgAoCoTB7_R877dVzkbxiQQihQirNMqS3lYp9S9MEsY9PZ-GiAmCEjMzdDFGaIwgwZmeeMzCarRy8PrGedr3fiv1AycLYFHprWP766sRldjoYq-3jrN2nlNzvfxjsjJJPc_LmcGBhPf19fVRNzxZ4AzOCrIQ</recordid><startdate>201203</startdate><enddate>201203</enddate><creator>Wurster, T.</creator><creator>Stellos, K.</creator><creator>Geisler, T.</creator><creator>Seizer, P.</creator><creator>Andia, M. E.</creator><creator>Schuster, A.</creator><creator>May, A. E.</creator><creator>Melms, A.</creator><creator>Gawaz, M.</creator><creator>Bigalke, B.</creator><general>Blackwell Publishing Ltd</general><general>John Wiley &amp; Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201203</creationdate><title>Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke?</title><author>Wurster, T. ; Stellos, K. ; Geisler, T. ; Seizer, P. ; Andia, M. E. ; Schuster, A. ; May, A. E. ; Melms, A. ; Gawaz, M. ; Bigalke, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4667-2ba0950077195e299c601a49c9fcd7fc3e39c83f82332826123f5e9fb2a4107a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angiogenesis</topic><topic>biomarkers</topic><topic>Biomarkers - blood</topic><topic>Blood Platelets - metabolism</topic><topic>C-reactive protein</topic><topic>Chemokine CXCL12 - analysis</topic><topic>Chemokine CXCL12 - blood</topic><topic>Data processing</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>Fluorescence</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Injuries</topic><topic>Ischemic Attack, Transient - blood</topic><topic>Ischemic Attack, Transient - diagnosis</topic><topic>Male</topic><topic>Myocardial infarction</topic><topic>P-selectin</topic><topic>Platelets</topic><topic>Regeneration</topic><topic>SDF-1</topic><topic>SDF-1 protein</topic><topic>Smoking</topic><topic>Stem cells</topic><topic>Stroke</topic><topic>Stroke - blood</topic><topic>Stroke - diagnosis</topic><topic>TIA</topic><topic>Transient ischemic attack</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wurster, T.</creatorcontrib><creatorcontrib>Stellos, K.</creatorcontrib><creatorcontrib>Geisler, T.</creatorcontrib><creatorcontrib>Seizer, P.</creatorcontrib><creatorcontrib>Andia, M. E.</creatorcontrib><creatorcontrib>Schuster, A.</creatorcontrib><creatorcontrib>May, A. E.</creatorcontrib><creatorcontrib>Melms, A.</creatorcontrib><creatorcontrib>Gawaz, M.</creatorcontrib><creatorcontrib>Bigalke, B.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wurster, T.</au><au>Stellos, K.</au><au>Geisler, T.</au><au>Seizer, P.</au><au>Andia, M. E.</au><au>Schuster, A.</au><au>May, A. E.</au><au>Melms, A.</au><au>Gawaz, M.</au><au>Bigalke, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke?</atitle><jtitle>European journal of neurology</jtitle><addtitle>Eur J Neurol</addtitle><date>2012-03</date><risdate>2012</risdate><volume>19</volume><issue>3</issue><spage>395</spage><epage>401</epage><pages>395-401</pages><issn>1351-5101</issn><eissn>1468-1331</eissn><coden>EJNEFL</coden><abstract>Background and purpose:  Platelet stromal‐cell‐derived factor‐1 (SDF‐1) plays a pivotal role in angiogenesis and the regeneration of ischaemic tissue through the regulation of haematopoietic progenitor cells and is upregulated at the sites of vascular injury and platelet activation. Thus, SDF‐1 has recently been discussed as a predictor in ischaemic diseases such as acute myocardial infarction. However, no clinical data pertinent to the investigation of the platelet SDF‐1 expression in patients with stroke are available. Methods:  We consecutively evaluated 196 patients who were admitted to the stroke unit with symptoms suspected for stroke. Surface expression of the platelet activation markers (P‐selectin and GPIb) and the expression of platelet‐bound SDF‐1 were determined by two‐colour whole blood flow cytometry. Results:  Patients with transient ischaemic attack (TIA) as well as with ischaemic stroke showed similar levels of SDF‐1 expression on hospital admission compared with patients with non‐ischaemic (NI) events and with 30 healthy controls (TIA (mean fluorescence intensity ± SD): 31.5 ± 18.2 vs. NI: 26.4 ± 15.7; P = 0.361; stroke: 28.7 ± 19.8 vs. NI; P = 0.943; control: 26.1 ± 11.3; P &gt; 0.05 compared with all). Platelet SDF‐1 expression showed a trend with the severity of stroke according to National Institute of Health Stroke Scale score (r = 0.125; P = 0.085), but significantly correlated with the peak levels of C‐reactive protein (r = 0.218; P = 0.002) and with the levels of platelet activation (P‐selectin: r = 0.389; P = 0.001). Multifactorial analysis of covariance revealed a significant influence on platelet SDF‐1 expression by smoking (P = 0.019). Conclusions:  Platelet SDF‐1 surface expression did not show any significant difference in patients with TIA and ischaemic stroke compared with patients with NI events. Thus, single biomarker evaluation of platelet SDF‐1 surface expression is not helpful to predict ischaemic stroke.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21951424</pmid><doi>10.1111/j.1468-1331.2011.03527.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1351-5101
ispartof European journal of neurology, 2012-03, Vol.19 (3), p.395-401
issn 1351-5101
1468-1331
language eng
recordid cdi_proquest_miscellaneous_926892579
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Aged, 80 and over
Angiogenesis
biomarkers
Biomarkers - blood
Blood Platelets - metabolism
C-reactive protein
Chemokine CXCL12 - analysis
Chemokine CXCL12 - blood
Data processing
Female
Flow Cytometry
Fluorescence
Hospitals
Humans
Injuries
Ischemic Attack, Transient - blood
Ischemic Attack, Transient - diagnosis
Male
Myocardial infarction
P-selectin
Platelets
Regeneration
SDF-1
SDF-1 protein
Smoking
Stem cells
Stroke
Stroke - blood
Stroke - diagnosis
TIA
Transient ischemic attack
title Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T04%3A41%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20stromal-cell-derived%20factor-1%20(SDF-1):%20a%20predictor%20of%20ischaemic%20stroke?&rft.jtitle=European%20journal%20of%20neurology&rft.au=Wurster,%20T.&rft.date=2012-03&rft.volume=19&rft.issue=3&rft.spage=395&rft.epage=401&rft.pages=395-401&rft.issn=1351-5101&rft.eissn=1468-1331&rft.coden=EJNEFL&rft_id=info:doi/10.1111/j.1468-1331.2011.03527.x&rft_dat=%3Cproquest_cross%3E926892579%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1766818853&rft_id=info:pmid/21951424&rfr_iscdi=true